/NHI

National Health Investors Inc

NHI

$70.32USD↑+0.16%+0.11 today

MARKET CAP

3.5B

P/E (TTM)

22.7x

FWD P/E

—

DAY RANGE

$70 – $71

52W RANGE

$68

$91

AI Summary

Stalk

Sell NowMedium

NHI remains in a Stage 4 declining regime with price below all major EMAs and SMAs and the primary Support Failure pattern confirming bearish medium-term asymmetry. Short- and long-term trends are down, and rallies into the falling 9-EMA and 21-EMA have been consistently rejected. While the RSI is approaching oversold, there is no sign of a sustained reversal, so the optimal approach is to initiate short exposure now in the resistance area around the short-term EMAs.

↑SHOP to 40-50% portfolio, targeting 8-9% NOI growth H2
↑EPS guidance $4.74-$4.79 vs consensus $4.87, upside potential
↓Q2 FFO flat at $1.19/share; net income boosted by $22M sales

Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	8.73 M	666.00 M	+3.93 M	+71.3%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	415.41 K	32.40 M	+-571.18 K	-60.1%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	200.12 K	15.26 M	+58.70 K	+33.5%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	130.12 K	9.92 M	+130.12 K	+0.0%	0.01%
MM Millennium Management LLC Q2 2026	SELL	79.03 K	6.03 M	+-682.97 K	-90.2%	0.00%
EP Eversept Partners, LP Q2 2026	BUYNEW	70.67 K	5.39 M	+70.67 K	+0.0%	0.28%
RT Renaissance Technologies LLC Q2 2026	BUY	52.10 K	3.97 M	+10.40 K	+17.8%	0.01%
JH Janus Henderson Group Plc Q1 2026	BUY	44.82 K	3.62 M	+25.31 K	+143.3%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	44.03 K	3.36 M	+-3.75 K	-13.1%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	782.00	59.63 K	+-73.00	-13.7%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-8.19 K	-100.0%	0.00%